Catalyst Pharmaceutical Partners Adopts Stockholder Rights Plan – Yahoo Finance
Cocaine Addiction: Catalyst Pharmaceutical Partners Adopts Stockholder Rights Plan – Yahoo Finance
Catalyst has two products in development, and is currently evaluating its lead product and first-in-class GABA aminotransferase inhibitor candidate, CPP-109 (vigabatrin), for the treatment of cocaine addiction. CPP-109 has been granted “Fast Track” status …
Cocaine Addiction – Bing News
Find More Cocaine Addiction Information…
<BR%20/>Tags: Partners, Stockholder, YAHOO, Adopts, Pharmaceutical, Finance <BR%20/>